InnoCare Pharma Ltd.SSE: 688428

Announcement on Results of Shareholding Reduction by Directors and Senior Management Members

Jul 21, 2026 · Issued by InnoCare Pharma Ltd. via Shanghai Stock Exchange

Filed with SSE · Jul 21, 2026 · 7 pages · Chinese

On 6ix: 6ix.com/news/innocare-pharma-limitedannouncement-on-results-of-shareholding-reduction-by-directors-and-senior-management-members

Release

Announcement on Results of Shareholding Reduction by Directors and Senior Management Members

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

InnoCare Pharma Ltd. on 6ix

Earlier from InnoCare Pharma

Announcement on Voluntary Disclosure of Soficitinib (ICP-332) Achieving the Primary Endpoint in a Phase II Study for the Treatment of Non-segmental VitiligoJul 17
InnoCare Announces Phase III Study Results of TYK2 Inhibitor Soficitinib Meet Primary Endpoint in Patients with Atomic DermatitisJul 15
InnoCare Announces Publication in STTT (IF=81.2) of Phase 3 Results Showing Orelabrutinib Significantly Prolonged Progression-Free Survival in Treatment-Naïve CLL/SLLJul 14
Study Results of Orelabrutinib in Patients with SLE Published in the Journal of AutoimmunityJul 10
InnoCare Announces First Patient Dosed in Clinical Trial of Novel CDH17 targeted ADC ICP-B208 in ChinaJul 5

Later from InnoCare Pharma

InnoCare's TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis StudyJul 27
InnoCare Announces Orelabrutinib in Combination with Mesutoclax Granted Breakthrough Therapy Designation in ChinaAug 3
InnoCare Announces Approval of Head-to-Head Registrational Phase III Trial of Mesutoclax with Azacitidine versus Venetoclax with Azacitidine in Treatment-Naive AML in ChinaAug 17
InnoCare Reports 2026 Interim Results, Sustained Profitability and Key Milestones AchievedAug 24
Announcement on the Satisfaction of Vesting Conditions for the First Vesting Period of the Reserved Grant under the 2024 STAR Market Restricted Share Incentive PlanAug 26

All InnoCare Pharma news releases

Follow InnoCare Pharma into a list and get an email when it puts out news.

Follow InnoCare Pharma